Presentation

Correlation with disease burden and early detection of recurrence using a novel nucleosome-based plasma based assay in longitudinally monitored neuroblastoma patients

February 29, 2024

Share
Tweet
Share on Facebook
Share

Presentation title: “Correlation with disease burden and early detection of recurrence using a novel nucleosome-based plasma based assay in longitudinally monitored neuroblastoma patients.”

Presented at Precision Medicine Workshop Feb 2023

Himsworth et al

Download

Poster & Publications
Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients
Poster & Publications
Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA

Correlation with disease burden and early detection of recurrence using a novel nucleosome-based plasma based assay in longitudinally monitored neuroblastoma patients

Related Articles

Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients

Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

Contact